# Work report — P5

## Problem

The expanded private pain-point DOCX could contain new clinician evidence, but it mixes duplicated synthesis, proposed research, author assumptions, sensitive caregiver narratives, and uncited background material. Treating the whole document as oncologist findings would create false evidence, expose private health information, and distort the current P5 plan.

## Decision

Keep the raw DOCX private and publish only a de-identified structural analysis. Add four weak participant-account records from one independent source group; add caregiver/family psychosocial-support coordination as a research hypothesis; strengthen multi-provider record portability as a Candidate A fallback signal; reject unsupported numerical, causal, user-role, and clinical-risk claims. Candidate B remains the owner-selected P5 lane because V2 contains no answered tumour-board workflow. Pause external NCG/ECHO outreach and ask the internal clinical analyst first about provenance, methods, completed questionnaire answers, and repeated signals.

## Evidence

- Complete document conversion and review → 344 extracted text lines reviewed.
- DOCX package inventory → document text, 15 footer parts, styles, numbering, settings, theme, relationships, and embedded fonts; no media, comments, headers, footnotes, or endnotes containing additional evidence.
- Lines 1–64 → duplicate the original pain-point synthesis and are not independent confirmation.
- Lines 66–172 → proposed questionnaires, cohorts, solution mappings, and thresholds; no completed answers are present.
- Lines 174–295 → three sensitive caregiver accounts; only de-identified thematic paraphrases are retained.
- Lines 296–344 → uncited general care-team primer; not treated as clinician evidence.
- `research/PAIN_POINTS_V2_ANALYSIS.md` → publishes structure, source limits, safe deltas, rejected assumptions, and revised questions without narrative or identifying details.
- `EV-0045`–`EV-0048` → four weak records sharing `oncologist-pain-points-v2-private-source`; they cannot count as independent confirmations.
- New safe signals → counselling/psychosocial-support coordination in two selected accounts; multi-provider/additional-opinion/cross-city journeys; caregiver operational work; digital touchpoints coexisting with operational friction.
- Rejected unsupported statements → unsourced statistic and volume claims, universal caregiver-role claim, corporate-versus-public time assumption, resident-primary-user assertion, interaction-time threshold, causal home-atmosphere/response statement, and smart clinical-risk triage framing.
- First ledger validation correctly failed because new repository locators lacked line anchors; locators were corrected to exact public-analysis ranges before acceptance.
- `.gitignore` → `Oncologist Pain Points_v2.docx` and `chatroom_notes.md` remain excluded.
- No external email was sent.
- `python3 research/validate_ledger.py` → `PASS: 48 records valid; 48 retained; IDs and contradiction references consistent`.
- Cross-artifact validation → 36 independent source groups, 86 unique claim IDs, all evidence references resolve, and all 10 checkpoint reports retain the exact required headings.
- Public-artifact privacy scan → no configured phone, personal-name, email, absolute-user-path, private-key, or token patterns found.
- `serena memories check .` → no referential-integrity issues.

## Risks and gaps

- The authorship, recruitment method, participant mix, note-taking method, and completeness of the expanded source are unknown.
- It is unknown whether the proposed clinician questionnaire was administered or whether answers exist separately.
- The three caregiver accounts are selected and sensitive; within-source recurrence is not prevalence.
- The resident/junior chart-assembly role, clinic-flow mechanism, and caregiver-support owner remain unevidenced.
- Candidate A gains plausibility but still lacks a named preparer, frequency, and total person-time after verification.
- Candidate B still lacks a current target-site owner, acknowledgement path, staff time, and baseline.
- External outreach requires fresh point-of-risk approval if it resumes after internal clarification.

## Next

Use the private internal-analyst draft to clarify which V2 sections represent completed conversations, how many participants and specialties contributed, whether questionnaires were administered, whether de-identified answers exist, and whether tumour-board, caregiver-support, portability, resident/junior, or clinic-flow signals repeated independently. Record only de-identified method, role, setting, aggregate, and workflow evidence. Resume external operator outreach only if internal evidence remains insufficient.

## Sign-off needed

The owner must review the de-identified interpretation and any later analyst answers before changing the candidate ranking or product scope. Publishing the raw DOCX, contacting an external recipient, accepting unsupported statements, or starting product architecture remains unauthorised without separate owner approval.
